Kjell E Oberg

Summary

Affiliation: Uppsala University
Country: Sweden

Publications

  1. request reprint
    Oberg K, Eriksson B. Endocrine tumours of the pancreas. Best Pract Res Clin Gastroenterol. 2005;19:753-81 pubmed
    ..None of these can cure a patient with malignant disease. In future, therapy will be custom-made and based on current knowledge of tumour biology and molecular genetics...
  2. request reprint
    Oberg K, Lamberts S. Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future. Endocr Relat Cancer. 2016;23:R551-R566 pubmed
    ..This review summarizes the development and clinical success of somatostatin analogues. ..
  3. request reprint
    Oberg K, Kvols L, Caplin M, Delle Fave G, de Herder W, Rindi G, et al. Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system. Ann Oncol. 2004;15:966-73 pubmed
    ..We compare the efficacy of octreotide and lanreotide in reducing diarrhea and flushing. Side-effects are described and we provide practical information on somatostatin analog treatment...
  4. request reprint
    Oberg K. Genetics and molecular pathology of neuroendocrine gastrointestinal and pancreatic tumors (gastroenteropancreatic neuroendocrine tumors). Curr Opin Endocrinol Diabetes Obes. 2009;16:72-8 pubmed
    ..However, the WHO classification introduced in clinical practice will give more insight into genetic and molecular changes related to tumor subtypes...
  5. Oberg K. Pancreatic endocrine tumors. Semin Oncol. 2010;37:594-618 pubmed publisher
    ..In the future, treatment will be based on tumor biology and molecular genetics with the aim of so-called personalized medicine...
  6. Oberg K. The genetics of neuroendocrine tumors. Semin Oncol. 2013;40:37-44 pubmed publisher
    ..Genome-wide screening of different types of NETs can now be performed for a reasonable price and is likely to generate new insights into the tumor biology and carcinogenesis in various subtypes of NETs. ..

Locale

Collaborators

Detail Information

Publications6

  1. request reprint
    Oberg K, Eriksson B. Endocrine tumours of the pancreas. Best Pract Res Clin Gastroenterol. 2005;19:753-81 pubmed
    ..None of these can cure a patient with malignant disease. In future, therapy will be custom-made and based on current knowledge of tumour biology and molecular genetics...
  2. request reprint
    Oberg K, Lamberts S. Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future. Endocr Relat Cancer. 2016;23:R551-R566 pubmed
    ..This review summarizes the development and clinical success of somatostatin analogues. ..
  3. request reprint
    Oberg K, Kvols L, Caplin M, Delle Fave G, de Herder W, Rindi G, et al. Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system. Ann Oncol. 2004;15:966-73 pubmed
    ..We compare the efficacy of octreotide and lanreotide in reducing diarrhea and flushing. Side-effects are described and we provide practical information on somatostatin analog treatment...
  4. request reprint
    Oberg K. Genetics and molecular pathology of neuroendocrine gastrointestinal and pancreatic tumors (gastroenteropancreatic neuroendocrine tumors). Curr Opin Endocrinol Diabetes Obes. 2009;16:72-8 pubmed
    ..However, the WHO classification introduced in clinical practice will give more insight into genetic and molecular changes related to tumor subtypes...
  5. Oberg K. Pancreatic endocrine tumors. Semin Oncol. 2010;37:594-618 pubmed publisher
    ..In the future, treatment will be based on tumor biology and molecular genetics with the aim of so-called personalized medicine...
  6. Oberg K. The genetics of neuroendocrine tumors. Semin Oncol. 2013;40:37-44 pubmed publisher
    ..Genome-wide screening of different types of NETs can now be performed for a reasonable price and is likely to generate new insights into the tumor biology and carcinogenesis in various subtypes of NETs. ..